Qube Research & Technologies Ltd
Position in WHWK — Whitehawk Therapeutics, Inc.
CIK 1729829
LONDON, X0
Position in WHWK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$166,659
-$8,423 QoQ
Shares Held
48,307
-33.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WHWK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. WHWK ranks #162 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in WHWK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $166,659 | 48,307 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $175,082 | 72,348 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $17,622 | 12,071 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $513 | 106 | Shares | Sole | 2023-11-13 | |
| 2022-03-31 | $294,141 | 17,333 | Shares | Sole | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||